Rhythm Pharmaceuticals | 4:持股变动声明-高管 Shulman Joseph
Rhythm Pharmaceuticals | 144:拟议出售证券
Rhythm Pharmaceuticals | 10-Q:季度报表
Rhythm Pharmaceuticals | 8-K:Rhythm Pharmaceuticals Rhythm Pharmicals
Rhythm Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)
Rhythm Pharmaceuticals | DEF 14A:股东委托书决议
Rhythm Pharmaceuticals | ARS:年度报告
Rhythm Pharmaceuticals | DEFA14A:其他
Rhythm Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(8.3%),Joseph Edelman(8.3%)等
Rhythm Pharmaceuticals | 4:持股变动声明-高管 Mazabraud Yann
Rhythm Pharmaceuticals | 8-K:重大事件
Rhythm Pharmaceuticals | 4:持股变动声明-高管 German Christopher Paul
Rhythm Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(5.4%),Perceptive Life Sciences Master Fund, Ltd.(5.4%)等
Rhythm Pharmaceuticals | 8-K:重大事件
Rhythm Pharmaceuticals | 4:持股变动声明-高管 Shulman Joseph
Rhythm Pharmaceuticals | 4:持股变动声明-高管 Lee Jennifer Kayden
Rhythm Pharmaceuticals | 144:拟议出售证券
Rhythm Pharmaceuticals | SC 13D:超过5%持股股东披露文件-Perceptive Advisors LLC(5.4%),Perceptive Life Sciences Master Fund, Ltd.(5.4%)等
Rhythm Pharmaceuticals | 144:拟议出售证券
Rhythm Pharmaceuticals | 4:持股变动声明-高管 Smith Hunter C
暂无数据